50090-3556-4 |
50090-3556 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20180702 |
N/A |
ANDA |
ANDA209312 |
A-S Medication Solutions |
METHOCARBAMOL |
750 mg/1 |
60 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-4) |
50090-3556-6 |
50090-3556 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20180702 |
N/A |
ANDA |
ANDA209312 |
A-S Medication Solutions |
METHOCARBAMOL |
750 mg/1 |
100 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-6) |
50090-3556-7 |
50090-3556 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20180702 |
N/A |
ANDA |
ANDA209312 |
A-S Medication Solutions |
METHOCARBAMOL |
750 mg/1 |
12 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-7) |
70010-754-01 |
70010-754 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Granules Pharmaceuticals Inc. |
METHOCARBAMOL |
500 mg/1 |
100 TABLET, COATED in 1 BOTTLE (70010-754-01) |
70010-754-05 |
70010-754 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20200201 |
N/A |
ANDA |
ANDA209312 |
Granules Pharmaceuticals Inc. |
METHOCARBAMOL |
500 mg/1 |
500 TABLET, COATED in 1 BOTTLE (70010-754-05) |
35573-413-02 |
35573-413 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol |
TABLET, COATED |
ORAL |
20190930 |
N/A |
ANDA |
ANDA209312 |
Burel Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
100 TABLET, COATED in 1 BOTTLE (35573-413-02) |
35573-413-04 |
35573-413 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol |
TABLET, COATED |
ORAL |
20190930 |
N/A |
ANDA |
ANDA209312 |
Burel Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
500 TABLET, COATED in 1 BOTTLE (35573-413-04) |
35573-414-02 |
35573-414 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol |
TABLET, COATED |
ORAL |
20190930 |
N/A |
ANDA |
ANDA209312 |
Burel Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
100 TABLET, COATED in 1 BOTTLE (35573-414-02) |
35573-414-04 |
35573-414 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol |
TABLET, COATED |
ORAL |
20190930 |
N/A |
ANDA |
ANDA209312 |
Burel Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
500 TABLET, COATED in 1 BOTTLE (35573-414-04) |
51655-195-51 |
51655-195 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20221216 |
N/A |
ANDA |
ANDA209312 |
Northwind Pharmaceuticals, LLC |
METHOCARBAMOL |
500 mg/1 |
40 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-51) |
51655-195-52 |
51655-195 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20221216 |
N/A |
ANDA |
ANDA209312 |
Northwind Pharmaceuticals, LLC |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-52) |
51655-195-84 |
51655-195 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20221116 |
N/A |
ANDA |
ANDA209312 |
Northwind Pharmaceuticals, LLC |
METHOCARBAMOL |
500 mg/1 |
14 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-84) |
51655-205-20 |
51655-205 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20230108 |
N/A |
ANDA |
ANDA209312 |
Northwind Pharmaceuticals, LLC |
METHOCARBAMOL |
750 mg/1 |
20 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-205-20) |
51655-205-52 |
51655-205 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20230413 |
N/A |
ANDA |
ANDA209312 |
Northwind Pharmaceuticals, LLC |
METHOCARBAMOL |
750 mg/1 |
30 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-205-52) |
53002-3040-1 |
53002-3040 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
10 TABLET, COATED in 1 BOTTLE (53002-3040-1) |
53002-3040-2 |
53002-3040 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
20 TABLET, COATED in 1 BOTTLE (53002-3040-2) |
53002-3040-3 |
53002-3040 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
30 TABLET, COATED in 1 BOTTLE (53002-3040-3) |
53002-3040-6 |
53002-3040 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
500 mg/1 |
60 TABLET, COATED in 1 BOTTLE (53002-3040-6) |
53002-3591-2 |
53002-3591 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
20 TABLET, COATED in 1 BOTTLE (53002-3591-2) |
53002-3591-3 |
53002-3591 |
HUMAN PRESCRIPTION DRUG |
Methocarbamol |
Methocarbamol Tablets |
TABLET, COATED |
ORAL |
20190101 |
N/A |
ANDA |
ANDA209312 |
RPK Pharmaceuticals, Inc. |
METHOCARBAMOL |
750 mg/1 |
30 TABLET, COATED in 1 BOTTLE (53002-3591-3) |